
    
      The study will assess quality of life using the Functional Living Index of Emesis (FLIE)
      questionnaire and generate Real World Evidence in support of existing clinical trial data,
      including effectiveness and safety of AkynzeoÂ® in the real world setting for the prevention
      of Chemotherapy Induced Nausea and Vomiting (CINV) in patients receiving highly emetogenic
      chemotherapy (HEC).
    
  